Welcome to our dedicated page for EXELON SEC filings (Ticker: EXC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on EXELON's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into EXELON's regulatory disclosures and financial reporting.
Exelon Corporation ownership disclosure: BlackRock, Inc. reports beneficial ownership of 103,668,925 shares of Exelon common stock, representing 10.1% as set forth in this amendment dated 06/30/2026. The filing lists 95,799,095 shares as sole voting power and 103,668,925 as sole dispositive power.
Exelon Corp director Matthew C. Rogers received a grant of deferred phantom share equivalents as part of his compensation. On the transaction date, he acquired 778 deferred phantom share equivalents tied to Exelon common stock at a reference price of $46.62 per share. These units are held in his Exelon stock fund account within a multi-fund, non-qualified deferred compensation plan and will be settled in cash on a 1-for-1 basis when his board service ends. After this grant and dividend-related accruals, his balance in this plan totals 1,524 phantom share equivalents, including 7 units added through automatic dividend reinvestment.
Lillie Charisse R reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director Charisse R. Lillie received a grant of 5 deferred phantom share equivalents tied to Exelon common stock. These were awarded at a reference price of $46.62 per equivalent and increase her deferred phantom share balance to 3,896 equivalents.
The phantom share equivalents are held in an Exelon stock fund account within a multi-fund, non-qualified deferred compensation plan and will be settled in cash on a 1-for-1 basis after her service on the board ends. The balance includes 35 additional equivalents that accrued automatically through dividend reinvestment, highlighting this as compensation and deferral activity rather than open-market trading.
Cheshire Marjorie Rodgers reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director Marjorie Rodgers received a compensation grant of 442 deferred phantom share equivalents of Exelon common stock at a reference price of $46.62 per equivalent. This increased her balance in the Exelon stock fund account under a multi-fund, non-qualified deferred compensation plan to 10,547 phantom share equivalents.
These phantom share equivalents will be settled for cash on a 1-for-1 basis when her service on the board of directors ends. The balance includes 91 additional phantom share equivalents that accrued automatically through dividend reinvestment in the plan.
BOWERS WILLIAM P reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director William P. Bowers reported a compensation-related award of deferred phantom share equivalents tied to Exelon common stock. He received 925 phantom share equivalents at a reference value of $46.62 per share, increasing his balance in the Exelon stock fund account to 21,266 equivalents.
These phantom share equivalents are part of a multi-fund, non-qualified deferred compensation plan and will be settled in cash on a 1-for-1 basis after his service on the board ends. The reported balance also reflects 183 additional phantom share equivalents that accrued automatically through dividend reinvestment, indicating this is a cash-settled, deferred arrangement rather than an open-market stock purchase or sale.
Exelon Corporation and its utility subsidiaries reported solid Q1 2026 results, with consolidated operating revenues of $7,242 million compared with $6,714 million a year earlier. Net income attributable to common shareholders was $919 million, essentially flat versus $908 million, and diluted earnings per share held at $0.90.
Operating cash flow strengthened to $1,724 million from $1,200 million, while capital expenditures increased to $2,358 million, reflecting ongoing grid and infrastructure investment. Total assets were $117,545 million and long‑term debt was $47,859 million as of March 31, 2026.
Among the utilities, ComEd, PECO, BGE, Pepco, DPL and ACE all remained profitable, with BGE earning $298 million, PECO $278 million and Pepco Holdings $169 million. ACE also recorded a prior-period rate classification error correction that reduced Q1 2026 net income by $10 million, which management deemed not material.
Exelon Corporation reported first quarter 2026 GAAP earnings of $0.90 per share, unchanged from a year ago, and Adjusted (non-GAAP) operating earnings of $0.91 per share, down from $0.92. Consolidated operating revenues were $7.24 billion, up from $6.71 billion, as its utilities benefited from higher approved distribution and transmission rates, favorable weather at some units, and the absence of PECO customer surcharge credits, partly offset by higher depreciation, interest expense, and credit loss costs.
By utility, ComEd, PECO and BGE grew GAAP net income to $310 million, $278 million and $298 million, while PHI declined to $169 million due to a Pepco Maryland multi-year plan reconciliation and higher depreciation. Exelon affirmed full-year 2026 Adjusted operating earnings guidance of $2.81–$2.91 per share and continues to target Adjusted EPS compound growth near the top end of 5–7% from 2025 to 2029.
The company outlined a revised four‑year capital plan of $41.7 billion, supporting expected rate base growth of 7.9% and significant transmission investment. Operating cash flow rose to $1.72 billion, and the board declared a quarterly dividend of $0.42 per share. Management highlighted sustained top‑quartile reliability, progress on large-load transmission security agreements, and completion or pricing of a substantial portion of planned 2026 debt and longer-term equity financing.
Exelon Corporation reported the results of its Annual Meeting of Shareholders held on April 28, 2026. Shareholders of record as of March 2, 2026, were entitled to vote.
All nominated directors were elected, each receiving at least 92.8% of votes cast in favor. For example, Calvin G. Butler, Jr. received 840,779,094 votes for, or 99.2% of votes cast. Auditor ratification for 2026 passed, with 818,550,440 votes for, or 89.0% of votes cast, approving PricewaterhouseCoopers LLP as independent auditor. An advisory vote on executive compensation also passed, receiving 764,185,640 votes for, or 90.5% of votes cast.
Exelon Corp ownership filing: Vanguard Capital Management reports beneficial ownership of 76,934,260 shares of Exelon common stock, representing 7.51% of the class. The filing states Vanguard has sole voting power over 10,918,572 shares and sole dispositive power over 76,934,260 shares. The disclosure attributes holdings across Vanguard Capital Management LLC and affiliated business divisions per SEC Release No. 34-39538.
Segedi Bryan K reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director Bryan K. Segedi received a grant of 3,720 2026 Directors Restricted Stock Units (RSUs). These RSUs were awarded at no cash cost as part of the Exelon Long-term Incentive Plan.
The RSUs will fully vest and be settled on a 1-for-1 basis into Exelon common stock on April 28, 2027. Additional stock units will accrue through dividend reinvestment and will vest at the same time as the underlying award. Following this grant, Segedi holds 3,720 RSUs linked to Exelon common stock.